Sanmina Corporation
$10.01B- Market cap
- $10.64B
- Debt
- +$300.47M
- Cash
- −$926.27M
Capital structure 97% equity / 3% debt · EV / Revenue 1.23x · EV / EBITDA 22.02x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SANM stock price at premium vs TEVA $198.47 current versus $134.02 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TEVA's multiple
Implied fair value · at SANM's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SANM FY 2025 (ended Sep 27, 2025) · TEVA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 97% equity / 3% debt · EV / Revenue 1.23x · EV / EBITDA 22.02x
Capital structure 96% equity / 4% debt · EV / Revenue 2.35x · EV / EBITDA 9.92x
TEVA carries the larger enterprise value at $40.63B against $10.01B; SANM trades on the lower EV / Revenue multiple (1.23x vs 2.35x); TEVA on the lower EV / EBITDA (9.92x vs 22.02x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Sanmina Corporation · implied price per share
Bear
$82.13
Base
$96.02
Bull
$114.75
TEVA PHARMACEUTICAL INDUSTRIES LIMITED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.12x
0.23x
Net debt / EBITDA
Leverage against operating earnings
-1.38x
-0.42x
Cash and equivalents
Liquid reserves on the balance sheet
$926.27M
$3.56B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$300.47M
$1.82B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.